Mind Body Balance for Pediatric Migraine
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study ID
- NCT04715685
- Status
- Recruiting
Conditions
- Chronic Migraine
- Headache
- Headache Disorders
- Headache, Migraine
- Migraine
- Migraine Disorders
- Migraine With Aura
- Migraine Without Aura
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- 40 minute session — BEHAVIORALThe 40 minute session will include all of the content contained in the 20 minute session, but will include a greater explanation of each of the mind and body skills, followed by in vivo practice of each skill with the nurse. Sessions will also include review of home practice for each group.
- 20 minute session — BEHAVIORALFor participants randomized to the 20 minute session, content will include pain education, followed by brief explanations of each of the mind and body skills, in vivo diaphragmatic breathing practice and demonstration of use of biofeedback card. Sessions will also include review of home practice for each group.
- home practice e-health — BEHAVIORALParticipants will be provided and instructed on access to a migraine-specific interactive web portal, Migraine e-Health. This web-based tool actively guides participants in practicing evidence-based mind and body skills. Use of the Migraine -e-Health application for the high dose capitalizes on teaching participants mind and body skills while increasing accessibility due to implementation on mobile devices.
- home practice handout — BEHAVIORALParticipants will be given a handout of commercially available free apps relevant to the mind body skills introduced.
- phone call — BEHAVIORALThe dose of phone call will occur about 4 weeks following the face-to-face mind and body introduction session and will last approximately 5-10 minutes. The phone call will be used to promote adherence to home-practice and answer questions related to skill use/home practice completion.
Study Details
This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized treatment for headache day reduction.
Key Dates
- Start date
- Mar 9, 2021
- Status verified
- Mar 2026
- Primary completion
- May 1, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 260 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: 40 minute session, home practice e-health, phone callThis intervention arm consists of mind body skill introduction session that is 40 minutes in duration. The daily home practice component for headache management will utilize a migraine specific interactive web portal, Migraine e-health portal. This arm will also receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
- Experimental: 40 minute session, home practice e-health, no phone callThis intervention arm consists of mind body skill introduction session that is 40 minutes in duration. The daily home practice component for headache management will utilize a migraine specific interactive web portal, Migraine e-health portal. This arm will not receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
- Experimental: 40 minute session, home practice handout, phone callThis intervention arm consists of mind body skill introduction session that is 40 minutes in duration. The daily home practice component for headache management will utilize a handout with explanations of mind body skills and a home practice plan. This arm will also receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
- Experimental: 40 minute session, home practice handout, no phone callThis intervention arm consists of mind body skill introduction session that is 40 minutes in duration. The daily home practice component for headache management will utilize a handout with explanations of mind body skills and a home practice plan. This arm will not receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
- Experimental: 20 minute session, home practice e-health, phone callThis intervention arm consists of mind body skill introduction session that is 20 minutes in duration. The daily home practice component for headache management will utilize a migraine specific interactive web portal, Migraine e-health portal. This arm will also receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
- Experimental: 20 minute session, home practice e-health, no phone callThis intervention arm consists of mind body skill introduction session that is 20 minutes in duration. The daily home practice component for headache management will utilize a migraine specific interactive web portal, Migraine e-health portal. This arm will not receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
- Experimental: 20 minute session, home practice handout, phone callThis intervention arm consists of mind body skill introduction session that is 20 minutes in duration. The daily home practice component for headache management will utilize a handout with explanations of mind body skills and a home practice plan. This arm will also receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
- Experimental: 20 minute session, home practice handout, no phone callThis intervention arm consists of mind body skill introduction session that is 20 minutes in duration. The daily home practice component for headache management will utilize a handout with explanations of mind body skills and a home practice plan. This arm will not receive a follow up phone call 4 weeks after the introductory session to promote adherence to home practice.
Primary Outcome Measure
Change in number of headache days [ Time Frame: baseline to post treatment (8 weeks post randomization) ]
Central Contacts
- LeighAnn Chamberlin, MEd513-636-9739
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado/Children's Hospital Colorado | Aurora | Colorado | 80045 | - |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 |
Find similar trials in Aurora, CO
By condition
By specialty
Related Studies
- Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years OldPHASE4 · Recruiting · Upsher-Smith Laboratories · Birmingham, Alabama
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)PHASE3 · Recruiting · AbbVie · Huntsville, Alabama
- Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)PHASE3 · Enrolling By Invitation · AbbVie · Huntsville, Alabama
- Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsPHASE3 · Recruiting · Pfizer · Fort Smith, Arkansas